{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:52:38Z","timestamp":1786373558335,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People with advanced CKD are at high risk of mortality and morbidity from coronavirus disease 2019 (COVID-19). We measured rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and severe outcomes in a large population attending advanced CKD clinics during the first 21 months of the pandemic. We examined risk factors for infection and case fatality, and we assessed vaccine effectiveness in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective cohort study, we analyzed data on demographics, diagnosed SARS-CoV-2 infection rates, outcomes, and associated risk factors, including vaccine effectiveness, for people attending a province-wide network of advanced CKD clinics during the first four waves of the pandemic in Ontario, Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In a population of 20,235 patients with advanced CKD, 607 were diagnosed with SARS-CoV-2 infection over 21 months. The case fatality rate at 30 days was 19% overall but declined from 29% in the first wave to 14% in the fourth. Hospitalization and intensive care unit (ICU) admission rates were 41% and 12%, respectively, and 4% started long-term dialysis within 90 days. Significant risk factors for diagnosed infection on multivariable analysis included lower eGFR, higher Charlson Comorbidity Index, attending advanced CKD clinics for more than 2 years, non-White ethnicity, lower income, living in the Greater Toronto Area, and long-term care home residency. Being doubly vaccinated was associated with lower 30-day case fatality rate (odds ratio [OR], 0.11; 95% confidence interval [CI], 0.03 to 0.52). Older age (OR, 1.06 per year; 95% CI, 1.04 to 1.08) and higher Charlson Comorbidity Index (OR, 1.11 per unit; 95% CI, 1.01 to 1.23) were associated with higher 30-day case fatality rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>People attending advanced CKD clinics and diagnosed with SARS-CoV-2 infection in the first 21 months of the pandemic had high case fatality and hospitalization rates. Fatality rates were significantly lower in those who were doubly vaccinated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Podcast<\/jats:title>\n                    <jats:p>This article contains a podcast at https:\/\/dts.podtrac.com\/redirect.mp3\/www.asn-online.org\/media\/podcast\/CJASN\/2023_04_10_CJN0000000000000087.mp3<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000000000000087","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T08:24:33Z","timestamp":1675326273000},"page":"465-474","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Clinical Outcomes and Vaccine Effectiveness for SARS-CoV-2 Infection in People Attending Advanced CKD Clinics"],"prefix":"10.2215","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1316-4405","authenticated-orcid":false,"given":"Jian","family":"Roushani","sequence":"first","affiliation":[{"name":"Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doneal","family":"Thomas","sequence":"additional","affiliation":[{"name":"Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3334-0581","authenticated-orcid":false,"given":"Matthew J.","family":"Oliver","sequence":"additional","affiliation":[{"name":"Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada"},{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Ip","sequence":"additional","affiliation":[{"name":"Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Yeung","sequence":"additional","affiliation":[{"name":"Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Tang","sequence":"additional","affiliation":[{"name":"Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Scott","family":"Brimble","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada"},{"name":"Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[{"name":"British Columbia Provincial Renal Agency, Vancouver, British Columbia, Canada"},{"name":"Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"St. Paul's Hospital, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Hladunewich","sequence":"additional","affiliation":[{"name":"Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada"},{"name":"Department of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Cooper","sequence":"additional","affiliation":[{"name":"Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Blake","sequence":"additional","affiliation":[{"name":"Ontario Renal Network, Ontario Health, Toronto, Ontario, Canada"},{"name":"Division of Nephrology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,16]]},"reference":[{"issue":"8","key":"B1-20250823","doi-asserted-by":"crossref","first-page":"E278","DOI":"10.1503\/cmaj.202601","article-title":"COVID-19 in patients undergoing long-term dialysis in Ontario","volume":"193","author":"Taji","year":"2021","journal-title":"Can Med Assoc J."},{"issue":"8","key":"B2-20250823","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1007\/s00345-020-03567-4","article-title":"Association between chronic kidney disease and COVID-19-related mortality in New York","volume":"39","author":"Mohamed","year":"2021","journal-title":"World J Urol."},{"issue":"12","key":"B3-20250823","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3390\/jcm7120493","article-title":"The number of comorbidities predicts renal outcomes in patients with stage 3-5 chronic kidney disease","volume":"7","author":"Lee","year":"2018","journal-title":"J Clin Med."},{"issue":"5","key":"B4-20250823","doi-asserted-by":"crossref","first-page":"2000547","DOI":"10.1183\/13993003.00547-2020","article-title":"Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis","volume":"55","author":"Guan","year":"2020","journal-title":"Eur Respir J."},{"issue":"6","key":"B5-20250823","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2021.07.003","article-title":"Incidence and outcomes of COVID-19 in people with CKD: a systematic review and meta-analysis","volume":"78","author":"Chung","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"B6-20250823","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.ajkd.2021.08.006","article-title":"Understanding the burden of the COVID-19 pandemic for people with kidney disease","volume":"78","author":"Wetmore","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"7821","key":"B7-20250823","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature."},{"issue":"3","key":"B8-20250823","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.kint.2022.05.015","article-title":"A retrospective cohort study predicting and validating impact of the COVID-19 pandemic in individuals with chronic kidney disease","volume":"102","author":"Dashtban","year":"2022","journal-title":"Kidney Int."},{"issue":"8","key":"B9-20250823","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s11255-020-02740-3","article-title":"Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis","volume":"53","author":"Cai","year":"2021","journal-title":"Int Urol Nephrol."},{"issue":"12","key":"B10-20250823","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/ndt\/gfaa271","article-title":"Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey","volume":"35","author":"Ozturk","year":"2020","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"B11-20250823","doi-asserted-by":"crossref","first-page":"e0254525","DOI":"10.1371\/journal.pone.0254525","article-title":"COVID-19 incidence and mortality in non-dialysis chronic kidney disease patients","volume":"16","author":"Gibertoni","year":"2021","journal-title":"PLoS One."},{"issue":"8","key":"B12-20250823","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2215\/CJN.09730620","article-title":"COVID-19 in patients with kidney disease","volume":"15","author":"Ajaimy","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B13-20250823","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ndt\/gfaa314","article-title":"Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA","volume":"36","year":"2021","journal-title":"Nephrol Dial Transplant."},{"issue":"9","key":"B14-20250823","doi-asserted-by":"crossref","first-page":"e2123622","DOI":"10.1001\/jamanetworkopen.2021.23622","article-title":"Evaluation of the SARS-CoV-2 antibody response to the BNT162b2 vaccine in patients undergoing hemodialysis","volume":"4","author":"Yau","year":"2021","journal-title":"JAMA Netw Open."},{"issue":"4","key":"B15-20250823","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1681\/ASN.2021091262","article-title":"Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes in the maintenance dialysis population in Ontario, Canada","volume":"33","author":"Oliver","year":"2022","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B16-20250823","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.kint.2022.08.027","article-title":"COVID-19 vaccine effectiveness in patients with non-dialysis-dependent chronic kidney diseases: findings from a population-based observational study from British Columbia, Canada","volume":"102","author":"Atiquzzaman","year":"2022","journal-title":"Kidney Int."},{"issue":"2","key":"B17-20250823","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jama.2015.18202","article-title":"Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis","volume":"315","author":"Tangri","year":"2016","journal-title":"JAMA."},{"issue":"3","key":"B18-20250823","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/ckj\/sfab237","article-title":"Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes","volume":"15","author":"Roushani","year":"2022","journal-title":"Clin Kidney J."},{"issue":"10","key":"B24-20250823","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/ndt\/gfac209","article-title":"Outcome and effect of vaccination in SARS-CoV-2 Omicron infection in hemodialysis patients: a cohort study","volume":"37","author":"Ashby","year":"2022","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"B25-20250823","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2215\/CJN.16621221","article-title":"Severity of COVID-19 after vaccination among hemodialysis patients: an Observational Cohort Study","volume":"17","author":"Ashby","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B26-20250823","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s40615-020-00833-4","article-title":"Racial, economic, and health inequality and COVID-19 infection in the United States","volume":"8","author":"Abedi","year":"2021","journal-title":"J Racial Ethn Health Disparities."},{"key":"B28-20250823","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijid.2021.06.059","article-title":"Relative risks of COVID-19 fatality between the first and second waves of the pandemic in Ontario, Canada","volume":"109","author":"Hsu","year":"2021","journal-title":"Int J Infect Dis."},{"issue":"12","key":"B29-20250823","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41581-020-00349-4","article-title":"CKD is a key risk factor for COVID-19 mortality","volume":"16","author":"Gansevoort","year":"2020","journal-title":"Nat Rev Nephrol."},{"issue":"4","key":"B31-20250823","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/cid\/ciaa815","article-title":"The disproportionate impact of COVID-19 on racial and ethnic minorities in the United States","volume":"72","author":"Tai","year":"2021","journal-title":"Clin Infect Dis."},{"issue":"8","key":"B32-20250823","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1681\/ASN.2020111606","article-title":"Racial and neighborhood-level disparities in COVID-19 incidence among patients on hemodialysis in New York City","volume":"32","author":"Tummalapalli","year":"2021","journal-title":"J Am Soc Nephrol."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000000000087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:51Z","timestamp":1786369611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000000000087"}},"subtitle":["A Retrospective Provincial Cohort Study"],"short-title":[],"issued":{"date-parts":[[2023,2,16]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000000000087","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,16]]},"assertion":[{"value":"2022-09-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}